{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:48:33Z","timestamp":1792784913467,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003056","name":"Ente Cassa di Risparmio di Firenze","doi-asserted-by":"publisher","award":["2015.1002A2202.3931"],"award-info":[{"award-number":["2015.1002A2202.3931"]}],"id":[{"id":"10.13039\/501100003056","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ANCC-COOP\/Airalzh ONLUS","award":["0043966.30-10- 359 2014"],"award-info":[{"award-number":["0043966.30-10- 359 2014"]}],"id":[{"id":"https:\/\/ror.org\/02erjrm45","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004434","name":"University of Florence","doi-asserted-by":"publisher","award":["D.R.595\/2016"],"award-info":[{"award-number":["D.R.595\/2016"]}],"id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Italian Ministry of Education, University and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004769","name":"University of Pavia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bbagen.2019.129453","type":"journal-article","created":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T02:57:13Z","timestamp":1572317833000},"page":"129453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["S-Homocysteinylation effects on transthyretin: worsening of cardiomyopathy onset"],"prefix":"10.1016","volume":"1864","author":[{"given":"Manuela","family":"Leri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rebuzzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Caselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Luti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Natalello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Giorgetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Garagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Paoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Bucciantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2019.129453_bb0005","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12916-014-0130-5","article-title":"Cardiovascular risk factors and future risk of Alzheimer\u2019s disease","volume":"12","author":"de Bruijn","year":"2014","journal-title":"BMC Med."},{"issue":"5","key":"10.1016\/j.bbagen.2019.129453_bb0010","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00726-013-1465-5","article-title":"S-linked protein homocysteinylation: identifying targets based on structural, physicochemical and protein\u2013protein interactions of homocysteinylated proteins","volume":"44","author":"Silla","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbagen.2019.129453_bb0015","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1515\/CCLM.2005.188","article-title":"Molecular targeting by homocysteine; a mechanism for vascular pathogenesis","volume":"43","author":"Jacobsen","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"issue":"9b","key":"10.1016\/j.bbagen.2019.129453_bb0020","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1111\/j.1582-4934.2008.00417.x","article-title":"Cysteinylation and homocysteinylation of plasma protein thiols during ageing of healthy human beings","volume":"13","author":"Rossi","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbagen.2019.129453_bb0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mehy.2006.10.056","article-title":"Pathomolecular effects of homocysteine on the aging process: a new theory of aging","volume":"69","author":"Perez","year":"2007","journal-title":"Med. Hypotheses"},{"issue":"2","key":"10.1016\/j.bbagen.2019.129453_bb0030","doi-asserted-by":"crossref","first-page":"e31388","DOI":"10.1371\/journal.pone.0031388","article-title":"Homocysteinylated albumin promotes increased monocyte-endothelial cell adhesion and up-regulation of MCP1, Hsp60 and ADAM17","volume":"7","author":"Capasso","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2019.129453_bb0035","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.1074\/jbc.M207605200","article-title":"New insights into the tPA-annexin A2 interaction. Is annexin A2 CYS8 the sole requirement for this association?","volume":"278","author":"Roda","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2019.129453_bb0040","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1074\/jbc.M004124200","article-title":"Homocysteine inhibits inactivation of factor Va by activated protein C","volume":"276","author":"Undas","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2019.129453_bb0045","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1006\/bbrc.1999.1391","article-title":"Influence of homocysteine on matrix metalloproteinase-2: activation and activity","volume":"263","author":"Bescond","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2019.129453_bb0050","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/01.ATV.0000023899.93940.7C","article-title":"Homocysteine binds to human plasma fibronectin and inhibits its interaction with fibrin","volume":"22","author":"Majors","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.bbagen.2019.129453_bb0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejps.2012.05.006","article-title":"LDL S- homocysteinylation decrease in chronic kidney disease patients undergone lipid lowering therapy","volume":"47","author":"Zinellu","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bbagen.2019.129453_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/01.ATV.0000251536.49581.8a","article-title":"Targeting of metallothionein by L-homocysteine: a novel mechanism for disruption of zinc and redox homeostasis","volume":"27","author":"Barbato","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbagen.2019.129453_bb0065","doi-asserted-by":"crossref","first-page":"13019","DOI":"10.1073\/pnas.241406698","article-title":"Support for the multigenic hypothesis of amyloidosis: the binding stoichiometry of retinol-binding protein, vitamin A, and thyroid hormone influences transthyretin amyloidogenicity in vitro","volume":"98","author":"White","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2019.129453_bb0070","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archneur.62.7.1057","article-title":"Transthyretin-related familial amyloidotic polyneuropathy","volume":"62","author":"Ando","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbagen.2019.129453_bb0075","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types","volume":"120","author":"Rapezzi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bbagen.2019.129453_bb0080","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0014-5793(97)01398-7","article-title":"The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution","volume":"418","author":"Quintas","year":"1997","journal-title":"FEBS Lett."},{"issue":"51","key":"10.1016\/j.bbagen.2019.129453_bb0085","doi-asserted-by":"crossref","first-page":"17851","DOI":"10.1021\/bi981876+","article-title":"Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation","volume":"37","author":"Lashuel","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2019.129453_bb0090","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cca.2009.01.020","article-title":"Characterization of cysteine and homocysteine bound to human serum transthyretin","volume":"403","author":"Hanyu","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbagen.2019.129453_bb0095","doi-asserted-by":"crossref","first-page":"49707","DOI":"10.1074\/jbc.M306748200","article-title":"In vitro and in vivo interactions of homocysteine with human plasma transthyretin","volume":"278","author":"Lim","year":"2003","journal-title":"JBC"},{"issue":"1","key":"10.1016\/j.bbagen.2019.129453_bb0100","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bbrc.2003.08.089","article-title":"S-Homocysteinylation of transthyretin is detected in plasma and serum of humans with different types of Hyperhomocysteinemia","volume":"310","author":"Sass","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2019.129453_bb0105","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1073\/pnas.1317488111","article-title":"Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis","volume":"111","author":"Mangione","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bbagen.2019.129453_bb0110","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jmb.2008.04.002","article-title":"Conformational properties of the aggregation precursor state of HypF-N","volume":"379","author":"Campioni","year":"2008","journal-title":"J. Mol. Biol."},{"issue":"5","key":"10.1016\/j.bbagen.2019.129453_bb0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1515\/hsz-2015-0250","article-title":"Effect of molecular chaperones on aberrant protein oligomers in vitro: super-versus sub-stoichiometric chaperone concentrations","volume":"397","author":"Cappelli","year":"2016","journal-title":"Biol. Chem."},{"issue":"9","key":"10.1016\/j.bbagen.2019.129453_bb0120","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.bpj.2016.09.010","article-title":"Biochemical and electrophysiological modification of amyloid transthyretin on cardiomyocytes","volume":"111","author":"Sartiani","year":"2016","journal-title":"Biophys. J."},{"issue":"1","key":"10.1016\/j.bbagen.2019.129453_bb0125","doi-asserted-by":"crossref","first-page":"12508","DOI":"10.1038\/s41598-018-30995-5","article-title":"A FTIR microspectroscopy study of the structural and biochemical perturbations induced by natively folded and aggregated transthyretin in HL-1 cardiomyocytes","volume":"8","author":"Ami","year":"2018","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.bbagen.2019.129453_bb0130","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.2174\/092986712800269281","article-title":"Methods to evaluate the inhibition of TTR fibrillogenesis induced by small ligands","volume":"19","author":"Arsequell","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"50","key":"10.1016\/j.bbagen.2019.129453_bb0135","doi-asserted-by":"crossref","first-page":"29769","DOI":"10.1074\/jbc.M115.690172","article-title":"Transthyretin binding heterogeneity and anti-amyloidogenic activity of natural polyphenols and their metabolites","volume":"290","author":"Florio","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2019.129453_bb0140","doi-asserted-by":"crossref","first-page":"H823","DOI":"10.1152\/ajpheart.00986.2003","article-title":"Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function","volume":"286","author":"White","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.bbagen.2019.129453_bb0145","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/jcp.22908","article-title":"Mouse embryonic stem cells that survive \u03b3-rays exposure maintain pluripotent differentiation potential and genome stability","volume":"227","author":"Rebuzzini","year":"2012","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.bbagen.2019.129453_bb0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/01.RES.0000027865.61704.32","article-title":"Differentiation of pluripotent embryonic stem cells into cardiomyocytes","volume":"91","author":"Boheler","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbagen.2019.129453_bb0155","doi-asserted-by":"crossref","first-page":"14993","DOI":"10.1038\/srep14993","article-title":"Arsenic trioxide alters the differentiation of mouse embryonic stem cell into cardiomyocytes","volume":"5","author":"Rebuzzini","year":"2015","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bbagen.2019.129453_bb0160","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5301\/IJAO.2011.8510","article-title":"Video evaluation of the kinematics and dynamics of the beating cardiac syncytium: an alternative to the Langendorff method","volume":"34","author":"Fassina","year":"2011","journal-title":"Int. J. Artif Organs."},{"key":"10.1016\/j.bbagen.2019.129453_bb0165","doi-asserted-by":"crossref","first-page":"1731S","DOI":"10.1093\/jn\/136.6.1731S","article-title":"The Hordaland homocysteine study: a community-based study of homocysteine, its determinants, and associations with disease","volume":"136","author":"Refsum","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.bbagen.2019.129453_bb0170","doi-asserted-by":"crossref","first-page":"e44992","DOI":"10.1371\/journal.pone.0044992","article-title":"Distinct annular oligomers captured along the assembly and disassembly pathways of transthyretin amyloid protofibrils","volume":"7","author":"Pires","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2019.129453_bb0175","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2015.10.020","article-title":"Inhibitory effect of human serum albumin on Cu-induced A\u03b2(40) aggregation and toxicity","volume":"767","author":"Lu","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"50","key":"10.1016\/j.bbagen.2019.129453_bb0180","doi-asserted-by":"crossref","first-page":"19423","DOI":"10.1523\/JNEUROSCI.2561-13.2013","article-title":"Mechanisms of transthyretin inhibition of \u03b2-amyloid aggregation in vitro","volume":"33","author":"Li","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2019.129453_bb0185","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.bbadis.2013.09.011","article-title":"Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro","volume":"1832","author":"Cascella","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"1\u20132","key":"10.1016\/j.bbagen.2019.129453_bb0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mrgentox.2013.06.007","article-title":"Mouse embryonic stem cells irradiated with \u03b3-rays differentiate into cardiomyocytes but with altered contractile properties","volume":"756","author":"Rebuzzini","year":"2013","journal-title":"Mutat. Res."},{"issue":"11","key":"10.1016\/j.bbagen.2019.129453_bb0195","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1021\/bi301313b","article-title":"Age-related oxidative modifications of transthyretin modulate its amyloidogenicity","volume":"52","author":"Zhao","year":"2013","journal-title":"Biochemistry"},{"issue":"18","key":"10.1016\/j.bbagen.2019.129453_bb0200","doi-asserted-by":"crossref","first-page":"11887","DOI":"10.1074\/jbc.M709638200","article-title":"The modulation of transthyretin tetramer stability by cysteine 10 adducts and the drug diflunisal. Direct analysis by fluorescence-detected analytical ultracentrifugation","volume":"283","author":"Kingsbury","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"29","key":"10.1016\/j.bbagen.2019.129453_bb0205","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1021\/bi030077a","article-title":"Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions","volume":"42","author":"Zhang","year":"2003","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.bbagen.2019.129453_bb0210","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.clnu.2017.07.005","article-title":"Relevance of plasma levels of free homocysteine and methionine as risk predictors for ischemic stroke in the young","volume":"37","author":"Rudreshkumar","year":"2018","journal-title":"Clin. Nutr."},{"issue":"2","key":"10.1016\/j.bbagen.2019.129453_bb0215","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.amjcard.2008.03.022","article-title":"Prognostic value of free plasma homocysteine levels in patients hospitalized with acute coronary syndrome","volume":"102","author":"van Oijen","year":"2008","journal-title":"Am. J. Cardiol."},{"issue":"11","key":"10.1016\/j.bbagen.2019.129453_bb0220","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1089\/ars.2007.1809","article-title":"Molecular targeting of proteins by L-homocysteine: mechanistic implications for vascular disease","volume":"9","author":"Glushchenko","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbagen.2019.129453_bb0225","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/0026-0495(93)90202-Y","article-title":"Redox status and protein binding of plasma homocysteine and other aminothiols in patients with homocystinuria","volume":"42","author":"Mansoor","year":"1993","journal-title":"Metabolism"},{"issue":"18","key":"10.1016\/j.bbagen.2019.129453_bb0230","doi-asserted-by":"crossref","first-page":"8368","DOI":"10.1073\/pnas.91.18.8368","article-title":"Transthyretin sequesters amyloid beta protein and prevents amyloid formation","volume":"91","author":"Schwarzman","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.bbagen.2019.129453_bb0235","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1073\/pnas.0712197105","article-title":"Transthyretin protects Alzheimer\u2019s mice from the behavioral and biochemical effects of Abeta toxicity","volume":"105","author":"Buxbaum","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416519302399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416519302399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:02:38Z","timestamp":1759636958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416519302399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0304416519302399"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2019.129453","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S-Homocysteinylation effects on transthyretin: worsening of cardiomyopathy onset","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2019.129453","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129453"}}